Biomed is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 2002. Biomed is a prominent player in the Indonesian pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company was founded by a group of visionary entrepreneurs with a mission to improve healthcare accessibility and quality in Indonesia. Biomed's primary business line is pharmaceuticals, with a secondary focus on healthcare solutions and medical devices. The company offers a diverse portfolio of products, including prescription medications, over-the-counter drugs, and health supplements. Some of their well-known product brands include BioPharm, MediCare, and VitaHealth. Biomed operates several branches across Indonesia, with a strong presence in major cities such as Surabaya, Bandung, and Medan. The company has also expanded its operations internationally, exporting its products to several countries in Southeast Asia and beyond. Biomed collaborates with various international pharmaceutical companies and research institutions to enhance its product offerings and stay at the forefront of medical innovation. The company is a member of several industry associations, including the Indonesian Pharmaceutical Association and the International Federation of Pharmaceutical Manufacturers & Associations. Biomed is committed to sustainable practices and corporate social responsibility, aiming to contribute positively to society and the environment. The company's vision is to become a leading pharmaceutical company in Asia, dedicated to improving health outcomes through innovative and affordable healthcare solutions.
Headquarters
Jl. Palmerah Utara No. 61A RT. 001 RW. 001
Central Jakarta; Jakarta;
Postal Code: 10270
Contact Details: Purchase the PT Biomed report to view the information.
Website: http://www.appeton.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service